Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
OOEP antisense RNA 1 (OOEP-AS1) is a long non-coding RNA (lncRNA) transcribed antisense to the OOEP gene, located on human chromosome 6[1]. As a natural antisense transcript (NAT), OOEP-AS1 is part of a class of RNA molecules that regulate gene expression at multiple levels, including transcriptional interference, modulation of chromatin structure, and possibly by affecting RNA splicing or stability[2][5]. These RNAs do not encode proteins and instead function through RNA-RNA, RNA-DNA, or RNA-protein interactions. The biological functions of NATs, including OOEP-AS1, include regulating the transcription of their sense counterparts, influencing chromatin state, and affecting alternative splicing, with broader roles in processes such as genomic imprinting and cellular responses to stress[2][5]. While some antisense RNAs play direct roles in disease such as cancer through modulation of oncogenes or tumor suppressors, there is currently no disease-specific or drug-targeting information for OOEP-AS1 itself.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on OOEP antisense RNA 1 (OOEP-AS1).